CSI Market
Sign In | Register

Pharmacyte Biotech Inc (PMCB) Annual Income Statement

Annual · GAAP · USD millions
Access PMCB quarterly income statements →
The data below summarizes Pharmacyte Biotech Inc's income statement results from Apr 30 2022 to Apr 30 2026, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
2026 		(Apr 30 2025) (Apr 30 2024) (Apr 30 2023) (Apr 30 2022)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing4.91
Research and Development Expense0.39
Restructuring, Accretion & Impairment Charges1.55
Other Operating Expense / -Income0.00
Total operating costs including COS6.85
Operating income / -loss-6.85
Interest Expense0.00
Interest Income0.73
Net Interest (-)Expense / Income0.00
Marketable Securities, Unrealized Gain (Loss)-0.41
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes0.00
Income after income taxes0.00
Income / -loss from continuing operations-19.42
Preferred dividends3.78
Net income / -loss-19.42
Income / -loss to shareholder-23.21
EBIT0.00
EBITD0.00
EBITDA0.00
Earnings Per Share
Basic EPS (excl. extra items)-2.77
Basic Net EPS-2.77
Basic shares outstanding (Mill. of Units)8.38
Diluted Net EPS-2.77
Diluted average shares (Mill. of Units)8.38
4 historic quarters locked

Sign in to unlock the full Pharmacyte Biotech Inc income statement history.

Sign In Create Free Account

About Pharmacyte Biotech Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.